指南与共识肝病

ACG临床指南:肝病中的营养不良与营养建议

ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.
指南 / 共识 · Am J Gastroenterol · 2025-05-02

该指南由美国胃肠病学院实践参数委员会制定,采用GRADE系统评估证据等级和推荐强度。指南指出肝硬化及酒精相关性肝炎患者应评估营养不良,并针对稳定门诊肝硬化患者、住院肝硬化患者、肝性脑病患者及代谢功能障碍相关脂肪性肝炎患者给出了具体的营养建议。

要点

  • 肝硬化及酒精相关性肝炎患者应评估营养不良,因其影响死亡率及肝移植等待和移植后结局。
  • 稳定门诊肝硬化患者应少食多餐、晚间加餐及每日饮用2杯以上咖啡。
  • 住院肝硬化患者口服摄入不足时应优先经肠内途径补充营养,不应限制蛋白质摄入。

核心结论

  • 肝硬化及酒精相关性肝炎患者应评估营养不良,营养不良对患者结局包括死亡率及肝移植等待和移植后结局有不良影响。

研究设计与样本

  • 本指南由美国胃肠病学院实践参数委员会制定,采用GRADE系统评估证据等级和推荐强度。

主要发现

  • 营养不良在肝病患者中常见,尤其在肝硬化患者中,可表现为孤立性微量营养素缺乏如锌缺乏,在晚期肝病患者中常表现为衰弱和/或肌少症。
  • 营养不良的患病率因评估方法和疾病严重程度而异,在晚期肝病患者中更高。
  • 在肝性脑病患者中,植物来源蛋白质似乎比动物来源蛋白质耐受性更好。
  • 支链氨基酸可增强乳果糖和利福昔明治疗肝性脑病的疗效。

关键数值与推荐

  • 稳定门诊肝硬化患者应接受咨询:少食多餐、晚上7点至10点之间加餐、每日饮用2杯或以上咖啡。
  • 在选定的代谢功能障碍相关脂肪性肝炎患者中,应提供维生素E 800 IU/d。
  • 住院肝硬化患者若经口摄入蛋白质和/或热量不足,应实施营养补充,最好经肠内途径。
  • 不应限制蛋白质摄入,包括失代偿期肝硬化及肝性脑病患者。

临床怎么用

  • 肝硬化及酒精相关性肝炎患者应评估营养不良。
  • 稳定门诊肝硬化患者应接受少食多餐、晚间加餐及每日咖啡的咨询。
  • 选定的代谢功能障碍相关脂肪性肝炎患者应提供维生素E 800 IU/d。
  • 住院肝硬化患者经口摄入不足时应优先经肠内途径补充营养。
  • 不应限制蛋白质摄入,包括失代偿期肝硬化及肝性脑病患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Malnutrition, defined as deficiency, excess, or imbalance of nutrients, is a common complication in patients with liver disease, especially those with cirrhosis. Malnutrition may present as an isolated micronutrient deficiency, such as zinc deficiency, and it commonly presents as frailty and/or sarcopenia in patients with advanced liver disease. Patients with cirrhosis and/or alcohol-associated hepatitis should be assessed for malnutrition because it adversely affects patient outcomes including mortality, as well as waitlist and posttransplant outcomes among liver transplant candidates. The prevalence of malnutrition varies based on the method of assessment and disease severity, being higher in those with advanced liver disease. Among stable outpatients with cirrhosis, counseling should be done to eat small frequent meals, a night-time snack between 7 PM and 10 PM, and 2 or more cups of coffee daily. In selected patients with metabolic dysfunction-associated steatohepatitis, vitamin E 800 IU/d should be provided. Among hospitalized patients with cirrhosis, nutritional supplementation preferably by enteral route should be implemented in those with poor oral intake of daily requirements of proteins and/or calories. Protein intake should not be restricted including patients with decompensated cirrhosis and hepatic encephalopathy. A vegetable source of protein seems to be better tolerated than an animal source of protein in patients with hepatic encephalopathy. Branched chain amino acids augment the efficacy of lactulose and rifaximin in the treatment of hepatic encephalopathy. Level of evidence and strength of recommendations were evaluated using the Grading of Recommendations, Assessment, Development, and Evaluations system. This guideline was developed under the auspices of the American College of Gastroenterology Practice Parameters Committee.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Singal AK, Wong RJ, Dasarathy S, et al. ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease. Am J Gastroenterol. 2025. PMID: 40314389. doi:10.14309/ajg.0000000000003379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。